Download PDF
TumorDiagnostik & Therapie 2017; 38(08): 507-514
DOI: 10.1055/s-0043-117149
Thieme Onkologie aktuell
© Georg Thieme Verlag KG Stuttgart · New York

Kurative endoskopische Therapie: Welche Läsionen eignen sich?

Johanna Munding
,
Andrea Tannapfel
Further Information

Publication History

Publication Date:
11 October 2017 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Dank flächendeckender Vorsorgeuntersuchungen werden immer mehr Tumore im Gastrointestinaltrakt so früh diagnostiziert, dass sie endoskopisch resezierbar sind. Doch nicht alle Läsionen eignen sich für eine kurative endoskopische Therapie. Abhängig ist dies vom lymphogenen Metastasierungsrisiko, das sich anhand histopathologischer Charakteristika abschätzen lässt.

 

  • Literatur

  • 1 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus, Langversion 1.0, 2015. AWMF Registernummer: 021/023OL
    PubMedGoogle Scholar
  • 2 Möhler M, Ebert M, Galle PR. et al. S3-Leitlinie Magenkarzinom: Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs. Z Gastroenterol 2011; 49: 461-531
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Pox C, Aretz S, Bischoff SC. et al. S3-guideline colorectal cancer version 1.0. Z Gastroenterol 2013; 51: 753-854
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Koop H, Fuchs KH, Labenz J. et al. S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021–013. Z Gastroenterol 2014; 52: 1299-1346
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Edgren G, Adami HO, Weiderpass E. et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013; 62: 1406-1414
    CrossrefPubMedGoogle Scholar
  • 6 Bollschweiler E, Knoppe K, Wolfgarten E. et al. Prevalence of reflux symptoms in the general population of Cologne. Z Gastroenterol 2007; 45: 177-181
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Labenz J, Koop H, Tannapfel A. et al. The epidemiology, diagnosis, and treatment of Barrett’s carcinoma. Dtsch Arztebl Int 2015; 112: 224-233 ; quiz 234
    PubMedGoogle Scholar
  • 8 Bosman FT, Carneiro F, Hruban RH. eds WHO Classification of Tumours of the Digestive System ed. World Health Orgn; 2010
    PubMedGoogle Scholar
  • 9 Wang GQ, Abnet CC, Shen Q. et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005; 54: 187-192
    CrossrefPubMedGoogle Scholar
  • 10 Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998; 123: 432-439
    CrossrefPubMedGoogle Scholar
  • 11 Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Kerkhof M, van Dekken H, Steyerberg EW. et al. Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007; 50: 920-927
    CrossrefPubMedGoogle Scholar
  • 13 Manner H, Pech O, Heldmann Y. et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013; 11: 630-635 ; quiz e645
    CrossrefPubMedGoogle Scholar
  • 14 Vieth M, Schubert B, Lang-Schwarz K. et al. Frequency of Barrett’s neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study. Endoscopy 2006; 38: 1201-1205
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Westerterp M, Koppert LB, Buskens CJ. et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504
    CrossrefPubMedGoogle Scholar
  • 16 Wittekind C, Meyer HJ. TNM Klassifikation maligner Tumore. Weinheim: Wiley-Blackwell; 2010
    Google Scholar
  • 17 Holscher AH, Bollschweiler E, Schroder W. et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011; 254: 802-807 ; discussion 807–808
    CrossrefPubMedGoogle Scholar
  • 18 Gronnier C, Messager M, Robb WB. et al. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma?. Surgery 2013; 154: 1093-1099
    CrossrefPubMedGoogle Scholar
  • 19 Kim YH, Kim JH, Kim H. et al. Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection?. Gastric Cancer 2015
    PubMedGoogle Scholar
  • 20 Huh CW, da Jung H, Kim JH. et al. Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surg Oncol 2013; 107: 124-129
    CrossrefPubMedGoogle Scholar
  • 21 Kim JH, Kim YH, da Jung H. et al. Follow-up outcomes of endoscopic resection for early gastric cancer with undifferentiated histology. Surg Endosc 2014; 28: 2627-2633
    CrossrefPubMedGoogle Scholar
  • 22 Wang Z, Zhang X, Hu J. et al. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology. J Visc Surg 2015; 152: 357-361
    CrossrefPubMedGoogle Scholar
  • 23 Guo CG, Zhao DB, Liu Q. et al. Risk Factors for Lymph Node Metastasis in Early Gastric Cancer with Signet Ring Cell Carcinoma. J Gastrointest Surg 2015; 19: 1958-1965
    CrossrefPubMedGoogle Scholar
  • 24 Kakushima N, Kanemoto H, Tanaka M. et al. Treatment for superficial non-ampullary duodenal epithelial tumors. World J Gastroenterol 2014; 20: 12501-12508
    CrossrefPubMedGoogle Scholar
  • 25 Brenner H, Chang-Claude J, Jansen L. et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014; 146: 709-717
    CrossrefPubMedGoogle Scholar
  • 26 Wasif N, Etzioni D, Maggard MA. et al. Trends, patterns, and outcomes in the management of malignant colonic polyps in the general population of the United States. Cancer 2011; 117: 931-937
    CrossrefPubMedGoogle Scholar
  • 27 Williams JG, Pullan RD, Hill J. et al. Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis 2013; 15 (Suppl. 02) 1-38
    PubMedGoogle Scholar
  • 28 Tanaka S, Asayama N, Shigita K. et al. Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: future perspectives. Dig Endosc 2015; 27: 216-222
    CrossrefPubMedGoogle Scholar
  • 29 Toh EW, Brown P, Morris E. et al. Area of submucosal invasion and width of invasion predicts lymph node metastasis in pT1 colorectal cancers. Dis Colon Rectum 2015; 58: 393-400
    CrossrefPubMedGoogle Scholar
  • 30 Delle Fave G, Kwekkeboom DJ, Van Cutsem E. et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012; 95: 74-87
    CrossrefPubMedGoogle Scholar
  • 31 Caplin M, Sundin A, Nillson O. et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012; 95: 88-97
    CrossrefPubMedGoogle Scholar
  • 32 Konishi T, Watanabe T, Kishimoto J. et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut 2007; 56: 863-868
    CrossrefPubMedGoogle Scholar